GlassScriptPhysician profile
Charles W Moniak
NPI 1366409096
$10,314.61
in general payments reported to CMS, 2019-2025
39 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,103 · 2020: $394 · 2021: $603 · 2022: $1,204 · 2023: $863 · 2024: $1,102 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,926 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.79 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,446.27 | 2019 | |
| Abbvie INC. | $1,288.56 | 2019-2025 | |
| Covidien LP | $1,000.00 | 2019 | |
| Pfizer INC. | $635.56 | 2019-2024 | |
| Biogen, INC. | $607.83 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $435.07 | 2023-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $343.21 | 2021-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $255.74 | 2022-2024 | Veozah |
| Allergan, INC. | $254.48 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $236.23 | 2022-2025 | |
| Exeltis, USA INC. | $194.45 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $178.30 | 2021-2023 | Injectafer |
| Therapeuticsmd, INC. | $154.45 | 2019-2022 | |
| Avion Pharmaceuticals | $145.34 | 2020-2022 | |
| Hologic Sales and Service, LLC | $131.26 | 2020-2025 | Aptima, Coolseal Generator |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $121.41 | 2021-2024 | Nexplanon |
| Baxter Healthcare | $100.65 | 2020-2024 | Perclot |
| Roche Diagnostics Corporation | $91.53 | 2019-2020 | |
| Millicent US INC | $88.47 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Aspira Women'S Health INC | $62.45 | 2022-2024 | Ova1 |
| Coopersurgical, INC. | $57.77 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $53.87 | 2023-2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $43.42 | 2022 | |
| Amag Pharmaceuticals, INC. | $42.94 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $40.79 | 2022-2023 | Vivjoa |
| Scynexis, INC. | $34.68 | 2022 | |
| Myovant Sciences INC. | $34.05 | 2022 | |
| Smith+Nephew, INC. | $33.65 | 2025 | Pico 7 |
| Mylan Pharmaceuticals INC. | $28.35 | 2021 | |
| Radius Health, INC. | $24.25 | 2020 | |
| Dexcom, INC. | $23.79 | 2023 | Dexcom G6 Transmitter |
| Medicem INC. | $19.51 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.91 | 2019 | |
| Becton, Dickinson and Company | $16.79 | 2024 | Bd Onclarity |
| Duchesnay USA Incorporated | $16.03 | 2019 | |
| Neuronetics, INC. | $15.51 | 2024 | Neurostar Tms Therapy System |
| Merck Sharp & Dohme LLC | $15.00 | 2021 | |
| Ethicon US, LLC | $13.86 | 2024 | Ethicon |
| Meditrina | $12.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Moniak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.